PARD3 Antibody (C-term) Blocking Peptide

Catalog Number: ABT-BP8678B
Article Name: PARD3 Antibody (C-term) Blocking Peptide
Biozol Catalog Number: ABT-BP8678B
Supplier Catalog Number: BP8678b
Alternative Catalog Number: ABT-BP8678B-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Partitioning defective 3 homolog, PAR-3, PARD-3, Atypical PKC isotype-specific-interacting protein, ASIP, CTCL tumor antigen se2-5, PAR3-alpha, PARD3, PAR3, PAR3A
PARD proteins, which were first identified in C. elegans, are essential for asymmetric cell division and polarized growth, whereas CDC42 (MIM 116952) mediates the establishment of cell polarity. The CDC42 GTPase, which is controlled by nucleotide exchange factors (GEFs, see MIM 606057) and GTPase-activating proteins (GAPs, see MIM 604980), interacts with a large set of effector proteins that typically contain a CDC42/RAC (MIM 602048)-interactive binding (CRIB) domain.
NCBI: 56288
UniProt: Q8TEW0
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP8678b was selected from the C-term region of human PARD3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.